Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 0 | |||||||||
| Gross profit | 0 | |||||||||
| Operating expense | 7,377.59%5.77M | 2,562.51%1.52M | 2,842.66%1.87M | 49.59%746.14K | 195.47%548.35K | -48.33%77.21K | -58.10%57.01K | 129.21%63.57K | 117.25%498.79K | 426.62%185.58K |
| Selling and administrative expenses | 4,985.57%3.89M | 507.12%341.57K | 1,361.61%929.13K | 58.71%449.37K | 157.22%253.83K | -28.32%76.46K | 12.41%56.26K | 129.21%63.57K | 42.86%283.14K | 654.45%98.68K |
| -Selling and marketing expense | --17.46K | --4.34K | --49.5K | --34.23K | --34.23K | --0 | --0 | --0 | --0 | ---- |
| -General and administrative expense | 4,962.74%3.87M | 499.41%337.23K | 1,283.75%879.64K | 46.62%415.15K | 122.54%219.6K | -28.32%76.46K | 12.41%56.26K | 129.21%63.57K | 42.86%283.14K | 654.45%98.68K |
| Other operating expenses | 251,246.27%1.89M | 156,744.27%1.18M | --941.49K | 37.61%296.76K | 238.91%294.51K | -98.25%750 | -99.13%750 | ---- | 586.73%215.65K | 292.15%86.9K |
| Operating profit | -7,377.59%-5.77M | -2,562.51%-1.52M | -2,842.66%-1.87M | -49.59%-746.14K | -195.47%-548.35K | 48.33%-77.21K | 58.10%-57.01K | -129.21%-63.57K | -117.25%-498.79K | -426.62%-185.58K |
| Net non-operating interest income (expenses) | -1,569.61%-1.7K | -483.70%-1.07K | -1,044.93%-1.58K | -3.14%-789 | -36.70%-365 | 49.50%-102 | 28.68%-184 | -263.16%-138 | -0.26%-765 | -27.14%-267 |
| Total other finance cost | 1,569.61%1.7K | 483.70%1.07K | 1,044.93%1.58K | 3.14%789 | 36.70%365 | -49.50%102 | -28.68%184 | 263.16%138 | 0.26%765 | 27.14%267 |
| Other net income (expenses) | 2.15K | 99.38%-794 | -127.36K | 0 | ||||||
| Gain on sale of security | --2.15K | ---- | ---- | ---794 | ---- | ---- | ---- | ---- | ---- | ---- |
| Special income (charges) | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- | ---127.36K | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --127.36K | --0 |
| Income before tax | -7,367.15%-5.77M | -2,555.82%-1.52M | -2,838.76%-1.87M | -19.27%-747.72K | -195.67%-549.5K | 48.33%-77.32K | 78.31%-57.19K | -129.39%-63.71K | -172.15%-626.91K | -424.26%-185.85K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -7,367.15%-5.77M | -2,555.82%-1.52M | -2,838.76%-1.87M | -19.27%-747.72K | -195.67%-549.5K | 48.33%-77.32K | 78.31%-57.19K | -129.39%-63.71K | -172.15%-626.91K | -424.26%-185.85K |
| Net income continuous operations | -7,367.15%-5.77M | -2,555.82%-1.52M | -2,838.76%-1.87M | -19.27%-747.72K | -195.67%-549.5K | 48.33%-77.32K | 78.31%-57.19K | -129.39%-63.71K | -172.15%-626.91K | -424.26%-185.85K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -7,367.15%-5.77M | -2,555.82%-1.52M | -2,838.76%-1.87M | -19.27%-747.72K | -195.67%-549.5K | 48.33%-77.32K | 78.31%-57.19K | -128.90%-63.71K | -172.15%-626.91K | -424.26%-185.85K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -7,367.15%-5.77M | -2,555.82%-1.52M | -2,838.76%-1.87M | -19.27%-747.72K | -195.67%-549.5K | 48.33%-77.32K | 78.31%-57.19K | -128.90%-63.71K | -172.15%-626.91K | -424.26%-185.85K |
| Diluted earnings per share | -0.16 | -0.06 | -0.08 | 0.00%-0.05 | -100.00%-0.04 | 0 | 0 | 0 | -204.10%-0.05 | -690.51%-0.02 |
| Basic earnings per share | -0.16 | -0.06 | -0.08 | 0.00%-0.05 | -100.00%-0.04 | 0 | 0 | 0 | -204.10%-0.05 | -690.51%-0.02 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.